Clinical Trial Update: Induction Immuno-chemotherapy and Concurrent Chemoradiotherapy With or Without Apatinib in Unresectable, Locally Advanced Esophageal Squamous Cell Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating induction immuno-chemotherapy and concurrent chemoradiotherapy with or without apatinib for unresectable, locally advan…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Squamous Cell Carcinoma

Drugs mentioned

• Apatinib (apatinib)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Esophageal Squamous Cell Carcinoma, Efficacy | Phase 2 | Status: ACTIVE_NOT_RECRUITING